Published in AIDS Weekly, April 17th, 2000
These scientists, part of a research team at the University Hospital of Geneva conducted a study comparing the initiation of antiviral therapy at primary HIV-1 infection (PHI) diagnosis, during chronic infection with CD4 counts greater than or equal to 500 (immunocompetent), and after development of immunosuppression ("Time of initiation of antiretroviral therapy: Impact on HIV-1 viremia," AIDS, 2000;14(3):243-249).
S. Yerly and colleagues examined antiviral effectiveness at each of the three levels of HIV infection. The groups...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.